Vaginitis in adolescents

Adolescent Medicine Clinics

Volumn 15, Issue 2, 2004, Pages 235-251

  Syed, Tahniat S ^a   Braverman, Paula K ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUTOCONAZOLE; CLINDAMYCIN; CLOTRIMAZOLE; CONTRACEPTIVE AGENT; DISULFIRAM; FLUCONAZOLE; METRONIDAZOLE; MICONAZOLE; NITROIMIDAZOLE; NONOXINOL 9; NYSTATIN; PYRROLE; TERCONAZOLE;

CLINICAL FEATURE; FOREIGN BODY; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATION; LACTOBACILLUS; OUTPATIENT; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; REVIEW; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA DISCHARGE; VAGINITIS; YEAST;

ADOLESCENT; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; CLINDAMYCIN; FEMALE; HUMANS; METRONIDAZOLE; PHYSICAL EXAMINATION; TRICHOMONAS VAGINITIS; VAGINOSIS, BACTERIAL;

EID: 3142570594     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.02.003     Document Type: Review

References (65)

1. Merchant J., Oh K., Klerman L. Douching: a problem for adolescents girls and young women. Arch Pediatr Adolesc Med. 153:1999;834-837
2. Nyirjesy P. Vaginitis in the adolescent patient. Pediatr Clin North Am. 46:1999;733-745
3. Mardh P.A. The vaginal ecosystem. Am J Obstet Gynecol. 165:1991;1163-1168
4. Carr P., Felsenstein D., Friedman R. Evaluation and management of vaginitis. J Gen Intern Med. 13:1998;335-346
5. Geiger A., Foxman B., Gillespie B. The epidemiology of vulvovaginal candidiasis among university students. Am J Pub Health. 85:1995;1146-1148
6. Foxman B. The epidemiology of vulvovaginal candidiasis: risk factors. Am J Public Health. 80:1990;329-331
7. Berg A.O., Heidrich F.E., Fihn S.D., Bergman J.J., Wood R.W., Stamm W.E. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA. 251:1984;620-625
8. Foxman B., Barlow R., D'Arcy H., Gillespie B., Sobel J.D. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 27:2000;230-235
9. DP Hamacher & Associates (Hamacher Resource Group) Stock Check. Feminine health care: a changing market share. Drug Topics. 1996;42-47
10. Holland J., Young M., Lee O., Chen S. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect. 79:2003;249-250
11. Nyirjesy P., Seeney S., Terry Grody M., Jordan C., Buckely H. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol. 173:1995;820-823
12. King R.D., Lee J., Morris A. Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect Immun. 27:1980;667-674
13. Spinillo A., Capuzzo E., Acciano S., De Santolo A., Zara F. Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am J Obstet Gynecol. 180(1 Pt 1):1999;14-17
14. Sobel J. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 14:1992;S148-S153
15. Sobel J. Pathophysiology of vulvovaginal candidiasis. J Reprod Med. 34:1989;S572-S580
16. Geiger A., Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology. 7:1996;182-187
17. Spinillo A., Pizzoli G., Colonna L., Nicola S., De Seta F., Guaschino S. Epidemiologic characteristics of women with idiopathic recurrent vulvovaginal candidiasis. Obstet Gynecol. 81:1993;721-727
18. Eckert L.O., Hawes S.E., Stevens C.E., Koutsky L.A., Eschenbach D.A., Holmes K.K. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol. 92:1998;757-765
19. Metzger G. Laboratory diagnosis of vaginal infections. Clin Lab Sci. 11:1998;47-52
20. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 51(RR-6):2002;1-80
21. Mathema B., Cross E., Dun E., Park S., Bedell J., Slade B., et al. Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals. Clin Infect Dis. 33:2001;e23-e27
22. Sobel J., Brooker D., Stein G. Single oral dose fluconazole compared with conventional clotrimazole tropical therapy of Candida vaginitis. Am J Obstet Gynecol. 172:1995;1263-1268
23. Sobel J., Faro S., Force R., Foxman B., Ledger W.J., Nyirjesy P.R., et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 178:1998;203-211
24. Cates W. Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 26:1999;52-57
25. Petrin D., Delgaty K., Bhatt R., Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 11:1998;300-317
26. World Health Organization An overview of selected curable sexually transmitted diseases. Global program on AIDS. 1995;World Health Organization, Geneva (Switzerland)
27. Cotch M., Pastorek J., Nugent R., Hillier S.L., Gibbs R.S., Martin D.H., et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginial Infections and Prematurity Study Group. Sex Transm Dis. 24:1997;353-360
28. Crosby R., DiCliemente R., Wingood G., Harrington K., Davies S.L., Hook E.W., et al. Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females. Sex Transm Dis. 78:2002;360-364
29. Alderete J., Provenzano D. The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases. Genitourin Med. 73:1997;291-296
30. Lehker M., Sweeney D. Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility. Sex Transm Infect. 75:1999;231-238
31. Wolner-Hanssen P., Krieger J., Stevens C., Kiviat N.B., Koutsky L., Critchlow C., et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 261:1989;571-576
32. Krieger J., Jenny C., Verdon M., Siegel N., Springwater R., Critchlow C., et al. Clinical manifestations of Trichomoniasis in men. Ann Intern Med. 118:1993;844-849
33. Wiese W., Patel S.R., Patel S.C., Ohl C., Estrada C. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med. 108:2000;301-308
34. Kingston M.A., Bansal D., Carlin E.M. 'Shelf life' of Trichomonas vaginalis. Int J STD AIDS. 14:2003;28-29
35. Ohlemeyer C., Hornberger L., Lynch D., Swierkosz E. Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy. J Adolesc Health. 22:1998;205-208
36. Borchardt K., Zhang M., Shing H., Flink K. A comparison of the sensitivity of the InPouch TV, Diamond's, and Trichosel media for detection of Trichomonas vaginalis. Genitourin Med. 73:1997;297-298
37. Lossick J., Kent H. Trichomonas: trends in diagnosis and management. Am J Obstet Gynecol. 165:1991;1219-1222
38. Paterson B., Tabrizi S., Garland S., Fairley C., Bowden F. The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex Transm Infect. 74:1998;136-139
39. Witkin S., Inglis S., Polaneczky M. Detection of Chlamydia trachomatis and Trichomonas vaginalis by polymerase chain reaction in introital specimens from pregnant women. Am J Obstet Gynecol. 175:1996;165-167
40. duBouchet L., McGregor J., Ismail M., McCormack W. A pilot study of metronidazole vaginal gel versus oral metronidazole for the treatment of Trichomonas vaginalis vaginitis. Sex Transm Dis. 25:1998;176-179
41. Pattman R. Recalcitrant vaginal trichomoniasis. Sex Transm Infect. 75:1999;127-128
42. Antonelli N., Diehl S., Wright J. A randomized trial of intravaginal nonoxynol 9 versus oral metronidazole in the treatment of vaginal trichomoniasis. Am J Obstet Gynecol. 182:2000;1008-1010
43. Sobel J., Nagappan V., Nyirjesy P. Metronidazole-resistant vaginal trichomoniasis-an emerging problem [correspondence]. N Engl J Med. 341:1999;292-293
44. Pearlman M., Yashar C., Ernst S., Solomon W. An incremental dosing protocol for women with severe vaginal trichomoniasis and adverse reactions to metronidazole. Am J Obstet Gynecol. 174:1996;934-936
45. Minkoff H., Grunebaum A., Schwarz R., Feldman J., Cummings M., Cromblehome W., et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol. 150:1984;965-972
46. Klebanoff M., Carey C., Hauth J., Hillier S.L., Nugent R.P., Thom E.A., et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med. 345:2001;487-493
47. Buve A., Weiss H., Laga M., Van Dyck E., Musonda R., Zekeng L., et al. The epidemiology of trichomonas in women in four African cities. AIDS. 15(Suppl 4):2001;S89-S96
48. Sorvillo F., Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet. 351:1998;213-214
49. Moodley P., Wilkinson D., Connolly C., Moodley J., Sturm A. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis. 34:2002;519-522
50. Hill G. The microbiology of bacterial vaginosis. Am J Obstet Gynecol. 169:1993;450-454
51. Schwebke J., Lawing L. Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polmerase chain reation. Sex Transm Dis. 28:2001;195-199
52. Amsel R., Totten P., Spiegel C., Chen K., Eschenbach D., Holmes K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 74:1983;14-22
53. Speigel C., Amsel R., Holmes K. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 18:1983;170-177
54. Nugent R., Krohn M., Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 29:1991;297-301
55. Taylor-Robinson D., Morgan D., Sheehan M., Rosenstein I., Lamont R. Relation between gram-stain and clinical criteria for diagnosing bacterial vaginosis with special reference to gram grade II evaluation. Int J STD AIDS. 14:2003;6-10
56. Lamont R., Hudson E., Hay P., et al. A comparison of the use of Papanicolaou-stained cervical cytological smears with gram-stained vaginal smears for the diagnosis of bacterial vaginosis in early pregnancy. Int J STD AIDS. 10:1999;93-97
57. Davis J., Connor E., Clark P., Wilkinson E., Duff P. Correlation between cervical cytologic results and gram stain as diagnostic tests for bacterial vaginosis. Am J Obstet Gynecol. 177:1997;532-535
58. Eschenbach D. Bacterial vaginosis: emphasis on upper genital tract complications. Obstet Gynecol Clin North Am. 16:1989;593-610
59. McGregor J., French J., Seo K. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol. 169:1993;463-466
60. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 189:2003;139-147
61. Peipert J., Montagno A., Cooper A., Sung J.C. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol. 177:1997;1184-1187
62. Sweet R. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis. 20:1995;S271-S275
63. Cook R., Redondo-Lopez V., Schmitt C., Meriwether C., Sobel J. Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol. 30:1992;870-877
64. Briselden A., Hillier S. Longitudinal study of the biotypes of Gardnerella vaginalis. J Clin Microbiol. 28:1990;2761-2764
65. Van Kessel K., Assefi N., Marrazzo J., Eckert L. Common complimentary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstet Gynecol Surv. 58:2003;351-358